OS Therapies

OSTX | AMEX

Price Alert Chart Builder DCF Calculator

$1.81

+$0.07 (+4.02%)

Sep 22, 2026, 10:22 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $79.24M

Enterprise Value $-125.8M

Beta -0.68

Average Volume 622.59K

Shares Outstanding (Diluted) 43.9M

Shares Change YoY 74.82%

Institutional Ownership 7.49%

Exchange AMEX

ISIN US68764Y2072

Price Performance

Price Change 1M 16.0%

Price Change 3M -4.4%

Price Change 6M 20.8%

Price Change YTD 29.9%

Price Change 1Y -21.3%

Price Change 3Y -56.5%

Price Change 5Y -56.5%

1M CAGR (ann.) 8.8%

1Y CAGR (ann.) -21.3%

5Y CAGR (ann.) N/A

All-Time CAGR -15.7%

Valuation

PE Ratio -1.60

Forward PE N/A

PEG Ratio 0.02

Forward PEG 0.02

PS Ratio N/A

Forward PS 3.00

PB Ratio -7.31

P/FCF Ratio -9.39

P/Adj. FCF Ratio -0.02

P/OCF Ratio -4.14

EV/Sales N/A

EV/EBIT 3.21

EV/EBITDA 0.01

EV/FCF 14.91

Earnings Yield -62.6%

FCF Yield -10.7%

Adj. FCF Yield -5392.2%

Financial Health

Net Cash $205.04M

Total Debt $0

Cash & Short-Term Investments $205.04M

Total Assets $6.26B

Current Ratio 0.18

Quick Ratio 0.18

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -464.76

Altman Z-Score 2.26

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -50544.0%

Returns

Return on Assets -397.8%

Return on Equity 683.0%

Return on Invested Capital 350.1%

Return on Capital Employed 350.1%

Return on Tangible Assets -1081.1%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -58.0%

EPS CAGR 5Y -30.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y -32.6%

FCF CAGR 5Y -99.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y 63.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.13

EPS Growth Est (next Q) -38.1%

Revenue Est (next Q) $1M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $16.50

Price Target Upside 848.3%

Cash Flow

Operating Cash Flow $-8.44M

Free Cash Flow $-8.44M

Adj. Free Cash Flow $-4.27B

FCF Per Share -$0.42

OCF Per Share -$0.42

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-374.81K

Operating Income $-37.61M

EBITDA $-8.61B

Net Income $-8.66B

EPS (Diluted) -$1.09

Revenue / Employee N/A

Profit / Employee $-1.73B

Employees 5